ANXA1 and gastric cancer: ANXA1 expression has been found to be increased in cancerous tissue versus adjacent or matched non-cancerous tissue in several tumour types including pancreatic [8], colorectal [9], lung [10] and gastric cancer [11], with high levels of ANXA1 expression often being associated with poor patient prognosis and lower overall survival [8, 11, 12].